FindTrial
Sign In

A study to compare the genetic profile of early and advanced stages of gallbladder adenocarcinoma cases who have not taken any chemotherapy and/or radiotherapy

A comparative study to evaluate results of next-generation sequencing and immunohistochemistry (PD-L1 and ALK-D5F3) in early and advanced stages of treatment-naive gallbladder adenocarcinoma - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/08/056775
Enrollment
40
Registered
2023-08-22
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K828- Other specified diseases of gallbladder

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: nil Control Intervention2: NIL: NIL

Sponsors

Mahamana Pandit Madan Mohan Malaviya cancer Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Cases are selected irrespective of age and sex

Exclusion criteria

Exclusion criteria: Patients who are treated with Neoadjuvant chemotherapy and/or radiotherapy before operative procedure FFPE tissues in which tumor tissue is inadequate for NGS testing Specimens of gall bladder coming from outside will not be included in our study

Design outcomes

Primary

MeasureTime frame
Genetic alteration Immunohistochemical expression of markers Histopathological parametersTimepoint: 1.5 year—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Paramita Rudra Pal

Mahamana Pandit Madan Mohan Malaviya Cancer Centre

drparamita14@gmail.com7627948180

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026